Evenamide (NW-3509)

About Newron Pharmaceuticals

Newron Pharmaceuticals is a development-stage biopharma focused on novel therapies for neurological diseases. Its primary achievement is the global approval and commercialization of Xadago® for Parkinson's disease, providing a revenue foundation. The company's strategy centers on advancing a pipeline of innovative small molecules for rare CNS disorders, leveraging strategic partnerships to maximize reach while retaining key rights. With a lean operational model, Newron aims to address significant unmet medical needs in neuroscience.

Therapeutic Areas